Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites across US states and Canadian provinces; removed prior location subsections and the HHS Vulnerability Disclosure as part of a revision.
    Difference
    2%
    Check dated 2025-12-23T17:16:47.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all be about the study. Revision updated to version v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:31:11.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The top government funding/operating status notice was removed from the page.
    Difference
    0.2%
    Check dated 2025-11-17T19:55:47.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Tainan City, Taiwan was removed and Tainan, Taiwan was added to the study locations. This aligns site naming with current common usage and improves accuracy for participants seeking nearby sites.
    Difference
    0.0%
    Check dated 2025-11-10T17:29:46.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The two screenshots show formatting and UI adjustments only, with core study details such as eligibility criteria, interventions, primary outcomes, and listed locations unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T13:52:46.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T04:26:29.000Z thumbnail image

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.